Quoin Pharmaceuticals Files 8-K
Ticker: QNRX · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-actions
TL;DR
Quoin Pharma filed a routine 8-K, no new info.
AI Summary
Quoin Pharmaceuticals, Ltd. filed an 8-K on February 27, 2025, reporting other events. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is incorporated in Israel and has its principal executive offices in Ashburn, VA. The filing does not disclose specific financial transactions or material events beyond its routine reporting.
Why It Matters
This 8-K filing indicates Quoin Pharmaceuticals is meeting its regulatory reporting obligations, but it does not contain new material information for investors at this time.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and does not disclose any new risks or material adverse information.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer
- Cellect Biotechnology Ltd. (company) — Former company name
- Cellect Biomed Ltd. (company) — Former company name
- February 27, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Quoin Pharmaceuticals, Ltd.?
The primary purpose of this 8-K filing is to report 'Other Events' as of February 27, 2025, fulfilling the company's current reporting obligations.
When was Quoin Pharmaceuticals, Ltd. previously known by other names?
Quoin Pharmaceuticals, Ltd. was formerly known as Cellect Biotechnology Ltd. (name change on July 21, 2016) and Cellect Biomed Ltd. (name change on April 6, 2016).
Where is Quoin Pharmaceuticals, Ltd. incorporated and what is its principal executive office address?
Quoin Pharmaceuticals, Ltd. is incorporated in the State of Israel and its principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
Does this filing disclose any specific new business developments or financial transactions?
This filing, categorized under 'Other Events,' does not disclose any specific new business developments or financial transactions beyond its routine reporting requirements.
What is the SIC code associated with Quoin Pharmaceuticals, Ltd.?
The Standard Industrial Classification (SIC) code associated with Quoin Pharmaceuticals, Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).